相关实验视频
Updated: Jul 27, 2025

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.7K
目前的状态和未来的方向在治疗ALS
Laura Tzeplaeff1, Sibylle Wilfling2,3, Maria Viktoria Requardt4
1Department of Neurology, Rechts der Isar Hospital, Technical University of Munich, 81675 München, Germany.
Cells
|June 10, 2023
概括
肌缩侧面硬化症 (ALS) 治疗由于原因不明而面临挑战. 目前的疗法提供适度的益处,但遗传研究和生物标志物为个性化医学和改善患者护理提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 遗传学 遗传学 是一个
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,影响运动神经元.
- 目前的治疗方法的疗效有限,这凸显了先进治疗策略的必要性.
- 在ALS中,各种病理途径使治疗开发复杂化.
研究的目的:
- 审查当前的肌缩侧面硬化症 (ALS) 疗法,包括已批准的药物和支持性护理.
- 讨论ALS治疗研究的新兴发展和未来前景.
- 强调生物标志物和基因测试在促进ALS个性化医学的作用.
主要方法:
- 对当前ALS治疗方法的文献综述.
- 分析最近在ALS的遗传向方面取得的突破.
- 讨论生物标志物在ALS患者分类中的重要性.
主要成果:
- 已批准的ALS药物 (Riluzole,Edaravone,Sodium phenylbutyrate/Taurursodiol) 对疾病的进展提供了适度的影响.
- 针对ALS遗传形式的重大进展正在出现.
- 生物标志物研究和基因测试对于个性化的ALS治疗策略至关重要.
结论:
- 虽然治疗ALS仍然难以捉摸,但正在进行的研究,特别是在遗传学方面,为改善患者结果提供了希望.
- 以生物标志物和遗传洞察为指导的个性化医疗方法是推动ALS护理的关键.
- 对ALS病理学的全面了解对于开发有效的疾病修饰疗法至关重要.
相关概念视频
Alzheimer's Disease: Treatment
224
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
224
Modeling in Therapy
128
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
128
Autism Spectrum Disorder
166
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
166
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536

